An increasing number of surgical treatments are performed for orthopedic pathologies in pets. Procedures such as arthrodesis or Tibial Tuberosity Advancement (TTA) have become reference treatments in cases of fractures or rupture of the cranial cruciate ligament (CCLD). Bone grafts, synthetic bone substitutes or metallic implants are often associated with these surgeries in order to improve bone repair and fusion but have various limitations in terms of availability, pain and risk of infection. Thanks to its properties, BIOCERA-VET ideally meets the characteristics expected by veterinarians in order to limit pain and the risks of infection and to promote bone repair and consolidation.
The clinical indications of BIOCERA-VET - BONE SURGERY - are:
- Corrective osteotomy
- TTA (Tibial Tuberosity Advancement)
- All indications for which bonegrafts are required
Osteosarcoma is a primary tumor of the bone that is the most common cancer in dogs and cats. Amputation of the affected limb is the treatment of choice, but it is not always possible (weakened animals, overweight, having already undergone an amputation, ...). Conservative therapy consisting in the removal of the tumor bone segment while maintaining limb function can be performed. Like amputation, this technique does not prevent cancer development and is often combined with chemotherapy in order to improve the quality of life and prolong the survival of the animal.
BIOCERA-VET provides an alternative of choice to amputation and to conservative treatment. Indeed, the injection of BIOCERA-VET into the bone cavity is intended to limit the pain, to reduce the risk of pathological fracture by reinforcing the structural strength of the affected bone tissue and improving mechanical support.
Osteoarthritis is the most common cause of lameness in pets and affects more than 34 million dogs worldwide. Current treatments combine a conservative approach (weight control and physiotherapy), drugs and surgery aimed at reducing pain and inflammation. These treatments may not be very effective or may be associated with significant side-effects or very invasive.
Considering its characteristics and unique mechanism of action (restoration of homeostasis, anti-inflammatory effects and tissue regeneration), VISCO-VET provides an effective and minimally invasive solution without side effects.
Cranial Cruciate Ligament Deficiency
Cranial cruciate ligament deficiency, affecting over 4 million dogs, is currently managed surgically. Deficiency of the cranial cruciate ligament is often a bilateral condition with increased risk of rupture of the contralateral ligament within 12 to 18 months following the initial diagnosis. Currently, no preventive treatment is available to avoid rupture of the contralateral ligament, which will therefore require a second surgical procedure.
By these pro-regenerative and anti-inflammatory properties, VISCO-VET offers an innovative and minimally invasive solution to prevent rupture of the contralateral ligament.
Tendon and ligament injuries
Tendon and ligament injuries (TLI) are a common cause of lameness in dogs. These lesions often appear as a result of a trauma or following micro-lesions caused by chronic stress. Currently, conservative treatments such as reduction of physical activity, use of anti-inflammatory drugs or intra-articular administration of steroids are encouraged. However, these treatments may lack effectiveness and are sometimes associated with side-effects. A surgical treatment is an alternative but is the source of frequent post-operative complications.
VISCO-VET combines local regenerative and anti-inflammatory effects promoting tissue regeneration essential for wound healing. VISCO-VET therefore is a treatment of choice in this indication.